Attenuation of diastolic heart failure and life-threatening ventricular tachyarrhythmia after peripheral blood stem cell transplantation combined with cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis.

Attenuation of diastolic heart failure and life-threatening ventricular tachyarrhythmia after peripheral blood stem cell transplantation combined with cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Attenuation of diastolic heart failure and life-threatening ventricular tachyarrhythmia after peripheral blood stem cell transplantation combined with cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis. Abstract Text:

Hiroyuki Yaoita,Masumi Iwai-Takano,Kazuei Ogawa,Hitoshi Suzuki,Kazuko Akutsu,Hideyoshi Noji,Yoshiyuki Kamiyama,Satoshi Kimura,Hideki Ohtake,Toshiyuki Ishibashi,Yukio Maruyama,Hiroyuki Yaoita,Masumi Iwai-Takano,Kazuei Ogawa,Hitoshi Suzuki,Kazuko Akutsu,Hideyoshi Noji,Yoshiyuki Kamiyama,Satoshi Kimura,Hideki Ohtake,Toshiyuki Ishibashi,Yukio Maruyama,

A patient had multiple myeloma and associated cardiac amyloidosis, which caused diastolic dysfunction and recurrent ventricular fibrillation. After implantation of a cardioverter-defibrillator (ICD), the patient underwent autologous peripheral blood stem cell transplantation (PBSCT). The life-threatening arrhythmias, such as ventricular fibrillation, disappeared, and diastolic dysfunction assessed by quantitative gated single photon emission computed tomography and Doppler echocardiography improved 7 months later. This may be the first report to document improvement of both a lethal rhythm disorder and diastolic dysfunction by PBSCT following ICD implantation in a case of cardiac amyloidosis associated with multiple myeloma. (Circ J 2008; 72: 331 - 334).

Attenuation of diastolic heart failure and life-threatening ventricular tachyarrhythmia after peripheral blood stem cell transplantation combined with cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis. Publishing Authors By Initials

H Yaoita,M Iwai-Takano,K Ogawa,H Suzuki,K Akutsu,H Noji,Y Kamiyama,S Kimura,H Ohtake,T Ishibashi,Y Maruyama,H Yaoita,M Iwai-Takano,K Ogawa,H Suzuki,K Akutsu,H Noji,Y Kamiyama,S Kimura,H Ohtake,T Ishibashi,Y Maruyama,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Attenuation of diastolic heart failure and life-threatening ventricular tachyarrhythmia after peripheral blood stem cell transplantation combined with cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Circulation journal : official journal of the Japa

VOLUME: 72

Page Numbers: 331-4

Journal Abbreviation: Circ. J.

ISSN: 1346-9843

DAY: 25

MONTH: Feb

YEAR: 2008

Attenuation of diastolic heart failure and life-threatening ventricular tachyarrhythmia after peripheral blood stem cell transplantation combined with cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101137683

Attenuation of diastolic heart failure and life-threatening ventricular tachyarrhythmia after peripheral blood stem cell transplantation combined with cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Attenuation of diastolic heart failure and life-threatening ventricular tachyarrhythmia after peripheral blood stem cell transplantation combined with cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Attenuation of diastolic heart failure and life-threatening ventricular tachyarrhythmia after peripheral blood stem cell transplantation combined with cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis.

AFFILIATION: First Department of Internal Medicine, Fukushima Medical University.

Country: Japan

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Circ J

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Attenuation of diastolic heart failure and life-threatening ventricular tachyarrhythmia after peripheral blood stem cell transplantation combined with cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis Related Publications

• 5'-O-Masked 2'-deoxyadenosine analogues as lead compounds for hepatitis C virus (HCV) therapeutic agents.
• A case of recurrent myocardial infarction caused by a giant right coronary artery aneurysm.
• A novel inhibitor of inducible nitric oxide synthase, ONO-1714, does not ameliorate hypoxia-induced pulmonary hypertension in rats.
• A transient increase in cerebrospinal fluid tau level after epileptic seizure in an elderly patient.
• Anti-angiogenic activities of nucleosides and nucleotides and their structure-activity relationship.
• Branched-chain Amino Acids and Alleviation of Muscle Damage and Fatigue in the Hyper-running Rat Model: 2071: Board #141 May 31 3:30 PM 5:00 PM.
• Comparative analysis of gene expression between renal cortex and papilla in nedaplatin-induced nephrotoxicity in rats.
• Difference in early effects of statin therapy on coronary and forearm flow reserve in postmenopausal hypercholesterolemic women.
• Downregulation of urokinase-type and tissue-type plasminogen activators in a rabbit model of renal ischemia/reperfusion.
• Ectopic bone formation by human bone morphogenetic protein-2 gene transfer to skeletal muscle using transcutaneous electroporation.
• Effect of actinins on the adenosinetriphosphatase activity of actomyosin at low ionic strength.
• Effect of poly(L-lysine)-g-dextran copolymers on DNA hybridization.
• Effect of the benzylic structure of lignan on antioxidant activity.
• Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome.
• Enhancement in the cleavage activity of a hammerhead ribozyme by cationic comb-type polymers and an RNA helicase in vitro.
• HMGB1 release in co-cultures of porcine endothelial and human T cells.
• High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes: response to Buzzetti et al.
• Microvascular thrombosis in the hepatic vein of a patient with paroxysmal nocturnal hemoglobinuria.
• Novel analysis for single nucleotide polymorphism using cationic comb-type copolymers.
• Physical exercises in the treatment of idiopathic scoliosis at risk of brace treatment - SOSORT consensus paper 2005.
• Preparation and some properties of alpha-actinin-free actin.
• Regulation of feeding behavior by pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) in vertebrates.
• Rotavirus associated acute encephalitis/encephalopathy and concurrent cerebellitis: report of two cases.
• Suppression of subgenomic hepatitis C virus replication by 5'-O-masked analogues of 6-chloropurine-2'-deoxyriboside.
• Synergetic antioxidant and vasodilatory action of carbon monoxide in angiotensin II - induced cardiac hypertrophy.
• Vasoconstrictive response in the vascular beds of the non-exercising forearm during leg exercise in patients with mild chronic heart failure.
• [Elucidation of the energy absorption spectra of the (11)C beam in a plastic scintillator.]
• [Evaluation of therapeutic carbon-beam attenuation in inhomogeneous layered phantoms: Comparison with the present method using a water phantom.]
• [Nationwide survey of nuclear medicine practice and estimation of collective effective dose in Japan.]
• [Practice of pharmaceutical care based on a clinical pharmaceutical research in a community pharmacy]